Intelligence · Clinical Pipeline
Novartis India Pipeline
All ClinicalTrials.gov programs at Novartis India — phase, modality, and trial IDs.
- Programs
- 28
Quick answer
Novartis India has 28 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
-, IPTACOPAN, -, -, -
Novartis Pharmaceuticals
IgA Nephropathy
1 trial -
Aliskiren
Novartis Pharmaceuticals
Hypertension
1 trial -
CERITINIB
Novartis Pharmaceuticals
non small cell lung cancer
1 trial -
Enteric-Coated Mycophenolate Sodium (EC-MPS)
Novartis Pharmaceuticals
Renal Transplant
1 trial -
Fluvirin(TIVf)
Novartis Pharmaceuticals
Influenza
1 trial -
INCLISIRAN SODIUM, BEMPEDOIC ACID, ATORVASTATIN, ROSUVASTATIN, EZETIMIBE
Novartis Pharmaceuticals
Hypercholesterolemia
1 trial -
IPTACOPAN HYDROCHLORIDE, IPTACOPAN
Novartis Pharmaceuticals
C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis
1 trial -
Indacaterol
Novartis Pharmaceuticals
Chronic Obstructive Pulmonary Disease
1 trial -
Jakavi 5 mg tablets, Jakavi 10 mg tablets, Jakavi 15 mg tablets, Jakavi 20 mg tablets, Jakavi 5 mg tablets, HDM201, RUXOLITINIB, Jakavi 20 mg tablets, Farydak 15 mg hard capsules, Jakavi 10 mg tablets, Jakavi 15 mg tablets, Jakavi 5 mg tablets, Farydak 10 mg hard capsules, Jakavi 10 mg tablets, Jakavi 15 mg tablets, HDM201, Jakavi 20 mg tablets
Novartis Pharmaceuticals
This study is designed to accept patients with varied disease origins, depending on the parent protocol
1 trial -
Kesimpta 20 mg solution for injection in pre-filled syringe
Novartis Pharmaceuticals
Relapsing forms of Multiple Sclerosis (RMS)
1 trial -
LETROZOLE, RIBOCICLIB, GOSERELIN ACETATE, LEE011, TAMOXIFEN
Novartis Pharmaceuticals
HR+, HER2- advanced or metastatic breast cancer
1 trial -
Mekinist, DRB436, DRB436, TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, DRB436, Mekinist 2 mg film-coated tablets
Novartis Pharmaceuticals
Children and Adolescents with Cancers Harboring V600 mutation.
1 trial -
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals
Neovacular Age-related Macular Degeneration
1 trial -
Ofatumumab
Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
1 trial -
Placebo of vildagliptin
Novartis Pharmaceuticals
Type 2 Diabetes Mellitus
1 trial -
Placebo to AIN457 150 mg/1 mL Solution for injection in pre-filled syringe, SECUKINUMAB
Novartis Pharmaceuticals
non-radiographic axial spondyloarthritis
1 trial -
Pluvicto 1 000 MBq/mL solution for injection/infusion
Novartis Pharmaceuticals
Prostate cancer
1 trial -
ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, Placebo to KJX839 (Inclisiran sodium) 0 mg/1.5 mL solution for injection in pre-filled syringe, INCLISIRAN
Novartis Pharmaceuticals
Hypercholesterolemia
1 trial -
Ribociclib
Novartis Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Rivastigmine
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
Rivastigmine transdermal patch
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
SEG101
Novartis Pharmaceuticals
Sickle cell disease
1 trial -
Secukinumab s.c. injection
Novartis Pharmaceuticals
Autoimmunity, Inflammation
1 trial -
TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, Mekinist 2 mg film-coated tablets, DRB436, DRB436, DRB436, TMT212
Novartis Pharmaceuticals
Multiple indications
1 trial -
Zoledronic Acid
Novartis Pharmaceuticals
Paget's Disease of the Bone
1 trial -
brinzolamide 1%/brimonidine 0.2% fixed combination
Novartis Pharmaceuticals
Glaucoma
1 trial -
carbidopa, levodopa, entacapone
Novartis Pharmaceuticals
Parkinson's Disease
1 trial -
dabrafenib
Novartis Pharmaceuticals
Melanoma
1 trial
Frequently asked questions
How many pipeline programs does Novartis India have?
28 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs